Major depression
RecruitingStudy on Psilocybin for Treating Depression in Cancer Patients
Study on Psilocybin for Treating Depression in Cancer Patients
- Disease:Major depression
- Substances:–
Sweden- Participants:18–64 years · 65+ years
Rare diseases
Investigational molecules
Locations
Study on Psilocybin for Treating Depression in Cancer Patients
SwedenStudy on the Effectiveness and Safety of Tislelizumab for Patients with Newly Diagnosed Hodgkin Lymphoma Who Cannot Have Standard Chemotherapy
ItalyStudy on Semaglutide and Low Energy Diet for Obesity in Adolescents Aged 12-17
NorwayStudy on the Effectiveness of Floxuridine with Gemcitabine and Oxaliplatin for Patients with Intra-hepatic Cholangiocarcinoma Not Suitable for Surgery
NorwayLong-Term Safety Study of MB-CART19.1, MB-CART20.1, and Zamtocabtagene Autoleucel for Patients with Advanced Melanoma or B-Cell Malignancies
GermanyStudy on Luspatercept for Improving Brain Oxygenation in Patients with Non-Transfusion Dependent Thalassemia
The NetherlandsLong-term Follow-up Study for Patients with Solid and Blood Cancers Treated with Brexucabtagene Autoleucel or Axicabtagene Ciloleucel
AustriaStudy on Vitrectomy, Alteplase, and Aflibercept for Patients with Wet Age-Related Macular Degeneration and Submacular Hemorrhage
GermanyStudy on EXL01 to Prevent Recurrence of C. difficile Infection in High-Risk Patients
FranceStudy on Letermovir and Valganciclovir for Treating CMV Infections in Kidney Transplant Patients
FranceStudy on Progesterone and Estradiol for Infertility in Patients Undergoing Hormone Replacement Therapy with Frozen Embryo Transfer
DenmarkStudy on PTG-CARCIK-CD19 for Adults and Children with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.